Literature DB >> 31161974

Computer-aided Quantification of Pulmonary Fibrosis in Patients with Lung Cancer: Relationship to Disease-free Survival.

Tae Iwasawa1, Koji Okudela1, Tamiko Takemura1, Taiki Fukuda1, Shoichiro Matsushita1, Tomohisa Baba1, Takashi Ogura1, Michihiko Tajiri1, Atsuko Yoshizawa1.   

Abstract

Background Interstitial lung abnormalities (ILAs) are present at CT in about 10% of individuals undergoing lung cancer screening. The relationship between histologic findings of ILAs and their influence on patient prognosis remains unknown. Purpose To evaluate the percentage of ILAs at preoperative CT, as measured by radiologists and a computer-aided detection (CAD) software, as a predictor of disease-free survival in patients with lung cancer. Materials and Methods This retrospective study evaluated 217 consecutive patients who underwent complete resection of lung cancer from April 2010 to December 2015. Two radiologists, blinded to the patients' clinical information, scored percentage fibrosis extent and determined whether ILAs and the usual interstitial pneumonia (UIP) pattern were present. They assessed ILA progression at follow-up CT. Two pathologists determined the presence of an UIP pattern. Percentage fibrosis extent was also measured by using CAD. Binary logistic regression analysis was performed to determine whether the CAD percentage fibrosis extent was associated with ILA at CT. Multivariable Cox regression analysis was used to evaluate the significance of CAD percentage fibrosis extent as a predictor of prognosis. Results The radiologists classified 47 patients with ILAs and 24 patients with a UIP pattern at chest CT. The pathologists detected a UIP pattern in 25 patients. CT abnormalities showed progression over a 2-year period in all patients with histologic evidence of UIP. After adjustment for age, sex, and smoking index, the CAD percentage fibrosis extent was independently associated with ILA (odds ratio: 3.1; 95% confidence interval [CI]: 2.1, 4.7; P < .001). After adjustment for age, forced expiratory volume in 1 second (percentage predicted) radiologist-assessed percentage fibrosis extent, and pathologic stage, CAD percentage fibrosis extent was independently associated with worse disease-free survival (hazard ratio: 1.3; 95% CI: 1.1, 1.6; P < .001). Conclusion Greater computer-aided detection percentage fibrosis extent at preoperative CT independently predicted worse disease-free survival in patients with lung cancer. © RSNA, 2019 Online supplemental material is available for this article. See also the editorial by Goo in this issue.

Entities:  

Mesh:

Year:  2019        PMID: 31161974     DOI: 10.1148/radiol.2019182466

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  7 in total

1.  Interstitial lung abnormalities detected incidentally on CT: a Position Paper from the Fleischner Society.

Authors:  Hiroto Hatabu; Gary M Hunninghake; Luca Richeldi; Kevin K Brown; Athol U Wells; Martine Remy-Jardin; Johny Verschakelen; Andrew G Nicholson; Mary B Beasley; David C Christiani; Raúl San José Estépar; Joon Beom Seo; Takeshi Johkoh; Nicola Sverzellati; Christopher J Ryerson; R Graham Barr; Jin Mo Goo; John H M Austin; Charles A Powell; Kyung Soo Lee; Yoshikazu Inoue; David A Lynch
Journal:  Lancet Respir Med       Date:  2020-07       Impact factor: 30.700

2.  Predictive Value of Interstitial Lung Abnormalities for Postoperative Pulmonary Complications in Elderly Patients with Early-stage Lung Cancer.

Authors:  Won Gi Jeong; Yun-Hyeon Kim; Jong Eun Lee; In-Jae Oh; Sang Yun Song; Kum Ju Chae; Hye Mi Park
Journal:  Cancer Res Treat       Date:  2021-09-28       Impact factor: 5.036

3.  Outcomes of Patients With Interstitial Lung Disease Receiving Programmed Cell Death 1 Inhibitors: A Retrospective Case Series.

Authors:  Ioana A Dobre; Angela J Frank; Kristin M D'Silva; David C Christiani; Daniel Okin; Amita Sharma; Sydney B Montesi
Journal:  Clin Lung Cancer       Date:  2021-02-04       Impact factor: 4.785

4.  Interstitial lung abnormalities in patients with stage I non-small cell lung cancer are associated with shorter overall survival: the Boston lung cancer study.

Authors:  Tomoyuki Hida; Akinori Hata; Junwei Lu; Vladimir I Valtchinov; Takuya Hino; Mizuki Nishino; Hiroshi Honda; Noriyuki Tomiyama; David C Christiani; Hiroto Hatabu
Journal:  Cancer Imaging       Date:  2021-01-19       Impact factor: 3.909

5.  Virtual screening and activity evaluation of multitargeting inhibitors for idiopathic pulmonary fibrosis.

Authors:  Rui Wang; Jian Xu; Rong Yan; Huanbin Liu; Jingxin Zhao; Yuan Xie; Wenbin Deng; Weiping Liao; Yichu Nie
Journal:  Front Pharmacol       Date:  2022-09-08       Impact factor: 5.988

Review 6.  [Update in Diagnosis of Idiopathic Pulmonary Fibrosis and Interstitial Lung Abnormality].

Authors:  Bo Da Nam; Jung Hwa Hwang
Journal:  Taehan Yongsang Uihakhoe Chi       Date:  2021-07-26

Review 7.  Interstitial Lung Abnormalities: State of the Art.

Authors:  Akinori Hata; Mark L Schiebler; David A Lynch; Hiroto Hatabu
Journal:  Radiology       Date:  2021-08-10       Impact factor: 29.146

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.